Aziyo Biologics, Inc.

Historical 13F Holders

Symbol
ELUT
CUSIP
05479K106
All holders as of
Q2 2026
Type
Equity
Class
CL A COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 05479K106 since 12/18/2024, newest first.

Filer % of Class Filed
SilverArc Capital Management, LLC 13G/A Amendment 2
4.9% 8/14/2026
Event 6/30/2026
SilverArc Capital Management, LLC 13G
4.9% 8/11/2026
Event 6/30/2026
Alyeska Investment Group, L.P. 13G/A Amendment 1
3.2% 2/17/2026
Event 12/31/2025
Knollwood Investment Advisory, LLC 13G 6.3% 2/13/2026
Event 12/31/2025
Nantahala Capital Management, LLC 13G/A Amendment 3
10.0% 2/13/2026
Event 12/31/2025
Orin Hirschman 13G/A Amendment 3
7.6% 1/28/2026
Event 12/31/2025
Kevin Rakin 13D/A Amendment 5
13.0% 12/15/2025
Event 12/11/2025
Alyeska Investment Group, L.P. 13G
7.2% 5/15/2025
Event 3/31/2025
Nantahala Capital Management, LLC 13G/A Amendment 2
10.0% 5/15/2025
Event 3/31/2025
HighCape Capital, L.P. 13D/A Amendment 4
26.4% 3/13/2025
Event 2/3/2025
SilverArc Capital Management, LLC 13G/A Amendment 1
5.9% 2/12/2025
Event 12/31/2024
Orin Hirschman 13G/A Amendment 2
9.9% 1/29/2025
Event 12/31/2024
Nantahala Capital Management, LLC 13G/A Amendment 1
10.0% 11/14/2024
Event 9/30/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 40 17.6 M $17.0 M
2026 Q1 35 15.2 M $16.0 M
2025 Q4 33 16.1 M $11.1 M
2025 Q3 31 18.1 M $16.1 M
2025 Q2 29 17.4 M $34.4 M
2025 Q1 32 17.2 M $43.6 M
2024 Q4 34 14.4 M $53.9 M
2024 Q3 32 13.5 M $51.8 M
2024 Q2 31 12.3 M $61.1 M
2024 Q1 26 7.35 M $23.1 M
2023 Q4 29 10.2 M $22.0 M
2023 Q3 23 8.25 M $11.6 M
2023 Q2 20 3.06 M $7.23 M
2023 Q1 19 2.78 M $4.20 M
2022 Q4 20 4.34 M $18.4 M
2022 Q3 18 3.33 M $24.0 M
2022 Q2 18 3.34 M $23.6 M
2022 Q1 18 3.29 M $19.4 M
2021 Q4 16 3.23 M $19.8 M
2021 Q3 18 1.90 M $13.2 M
2021 Q2 25 2.05 M $19.7 M
2021 Q1 33 1.70 M $23.5 M
2020 Q4 37 1.84 M $25.1 M